Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Mathew R. Lee
Observed name:
M Lee
Institution:
University of Colorado Anschutz
Observed institutions:
Carnegie Institution for Science,
Eulji University,
Daejeon Eulji Medical Center, Eulji University,
University of Colorado Anschutz,
University of Edinburgh
ORCID:
0009-0008-4352-3078
Observed ORCID:
0009-0008-4352-3078
OpenAlex ID:
A5114220058
Variegated transgene expression in mouse mammary gland is determined by the transgene integration locus.
1996
·
K W Dobie
, M Lee
, et al.
·
Proceedings of the National Academy of Sciences
·
170
PDF
A Phase II Study of Potentiation of Pembrolizumab with Binimetinib and Bevacizumab in Refractory Microsatellite-Stable Colorectal Cancer
2024
·
Robert W. Lentz
, Tyler J. Friedrich
, et al.
·
Clinical Cancer Research
·
14
Abstract P5-10-06: A functional role for miR-150 in breast cancer
2012
·
NC D'Amato
, H Gu
, et al.
·
Cancer Research
·
3
Nasopharyngeal undifferentiated carcinoma with sarcomatoid features: Pitfalls in the immunohistochemistry.
2019
·
M Lee
, H J Son
, et al.
·
PubMed
·
1
Supplementary Figure S2 from A Phase II Study of Potentiation of Pembrolizumab with Binimetinib and Bevacizumab in Refractory Microsatellite-Stable Colorectal Cancer
2024
·
Robert W. Lentz
, Tyler J. Friedrich
, et al.
Supplementary Figure S1 from A Phase II Study of Potentiation of Pembrolizumab with Binimetinib and Bevacizumab in Refractory Microsatellite-Stable Colorectal Cancer
2024
·
Robert W. Lentz
, Tyler J. Friedrich
, et al.
Supplementary Figure S4 from A Phase II Study of Potentiation of Pembrolizumab with Binimetinib and Bevacizumab in Refractory Microsatellite-Stable Colorectal Cancer
2024
·
Robert W. Lentz
, Tyler J. Friedrich
, et al.
Supplementary Figure S3 from A Phase II Study of Potentiation of Pembrolizumab with Binimetinib and Bevacizumab in Refractory Microsatellite-Stable Colorectal Cancer
2024
·
Robert W. Lentz
, Tyler J. Friedrich
, et al.
Supplementary Figure S5 from A Phase II Study of Potentiation of Pembrolizumab with Binimetinib and Bevacizumab in Refractory Microsatellite-Stable Colorectal Cancer
2024
·
Robert W. Lentz
, Tyler J. Friedrich
, et al.
Supplementary Figure S6 from A Phase II Study of Potentiation of Pembrolizumab with Binimetinib and Bevacizumab in Refractory Microsatellite-Stable Colorectal Cancer
2024
·
Robert W. Lentz
, Tyler J. Friedrich
, et al.
Data from A Phase II Study of Potentiation of Pembrolizumab with Binimetinib and Bevacizumab in Refractory Microsatellite-Stable Colorectal Cancer
2024
·
Robert W. Lentz
, Tyler J. Friedrich
, et al.
Supplementary Figure S2 from A Phase II Study of Potentiation of Pembrolizumab with Binimetinib and Bevacizumab in Refractory Microsatellite-Stable Colorectal Cancer
2024
·
Robert W. Lentz
, Tyler J. Friedrich
, et al.
Supplementary Figure S4 from A Phase II Study of Potentiation of Pembrolizumab with Binimetinib and Bevacizumab in Refractory Microsatellite-Stable Colorectal Cancer
2024
·
Robert W. Lentz
, Tyler J. Friedrich
, et al.
Supplementary Figure S7 from A Phase II Study of Potentiation of Pembrolizumab with Binimetinib and Bevacizumab in Refractory Microsatellite-Stable Colorectal Cancer
2024
·
Robert W. Lentz
, Tyler J. Friedrich
, et al.
Supplementary Figure S7 from A Phase II Study of Potentiation of Pembrolizumab with Binimetinib and Bevacizumab in Refractory Microsatellite-Stable Colorectal Cancer
2024
·
Robert W. Lentz
, Tyler J. Friedrich
, et al.
Supplementary Figure S8 from A Phase II Study of Potentiation of Pembrolizumab with Binimetinib and Bevacizumab in Refractory Microsatellite-Stable Colorectal Cancer
2024
·
Robert W. Lentz
, Tyler J. Friedrich
, et al.
Supplementary Table S1 from A Phase II Study of Potentiation of Pembrolizumab with Binimetinib and Bevacizumab in Refractory Microsatellite-Stable Colorectal Cancer
2024
·
Robert W. Lentz
, Tyler J. Friedrich
, et al.
Data from A Phase II Study of Potentiation of Pembrolizumab with Binimetinib and Bevacizumab in Refractory Microsatellite-Stable Colorectal Cancer
2024
·
Robert W. Lentz
, Tyler J. Friedrich
, et al.
Show more works
View as search
Works count:
18
Citation count:
188
H-index:
3
I10-index:
2
Year
Topic
Type